C07C 279/06
Being further substituted by halogen atoms, or by nitro or nitroso groups
Official title: being further substituted by halogen atoms, or by nitro or nitroso groups
C07C279/06 (Being further substituted by halogen atoms, or by nitro or nitroso groups) appears on 32 US grants and 40 published applications in this corpus.
Search patents in C07C- Granted patents
- 32
- Published applications
- 40
- Assignees
- 21
- Inventors
- 90
- Latest grant
- 10 Jun 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1990 | 2 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 2 | 0 |
| 1996 | 1 | 0 |
| 1997 | 2 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 1 |
| 2008 | 0 | 1 |
| 2009 | 2 | 0 |
| 2010 | 0 | 2 |
| 2011 | 0 | 0 |
| 2012 | 0 | 2 |
| 2013 | 1 | 2 |
| 2014 | 2 | 4 |
| 2015 | 2 | 2 |
| 2016 | 2 | 4 |
| 2017 | 2 | 4 |
| 2018 | 4 | 5 |
| 2019 | 3 | 3 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 3 | 2 |
| 2023 | 1 | 1 |
| 2024 | 1 | 2 |
| 2025 | 1 | 2 |
By publication year. Applications have been published since 2001.
Recent patents
- Ligands for imaging cardiac innervation10 Jun 2025US 12,324,845 B2Lantheus Medical Imaging, Inc.
- Therapeutic compounds11 Jun 2024US 12,006,294 B2Regents of the University of Minnesota
- Preparations of meta-iodobenzylguanidine and precursors thereof12 Dec 2023US 11,840,592 B2Molecular Insight Pharmaceuticals, Inc.
- Guanidine compounds and use thereof11 Oct 2022US 11,465,989 B2ImmunoMet Therapeutics Inc.
- Preparations of meta-iodobenzylguanidine and precursors thereof22 Mar 2022US 11,279,784 B2Molecular Insight Pharmaceuticals, Inc.
- Compositions, methods, and systems for the synthesis and use of imaging agents29 May 2025US 2025/0170282 A1Lantheus Medical Imaging, Inc.
- Ligands for imaging cardiac innervation22 May 2025US 2025/0161500 A1Lantheus Medical Imaging, Inc.
- Preparations of meta-iodobenzylguanidine and precursors thereof30 May 2024US 2024/0174782 A1Molecular Insight Pharmaceuticals, Inc.
- Contrast agent and precursor and manufacturing method thereof25 Jan 2024US 2024/0024518 A1Institute of Nuclear Energy Research Atomic Energy Council, Executive Yuan
- Preparations of meta-iodobenzylguanidine and precursors thereof12 Jan 2023US 2023/0008878 A1Molecular Insight Pharmaceuticals, Inc.
Most cited
By later US patents
- Compositions, methods, and systems for the synthesis and use of imaging agents23US 9,550,000 B2Lantheus Medical Imaging, Inc. · 2017
- Biguanide derivative, preparation method thereof, and pharmaceutical composition containing same as an active ingredient14US 9,133,110 B2Hanall Biopharma Co., Ltd. · 2015
- Fluoroalkenyl compounds and their use as pest repellents10US 5,389,680 AMonsanto Company · 1995
- Ligands for imaging cardiac innervation9US 8,491,868 B2Lantheus Medical Imaging, Inc. · 2013
- Inhibition of cell proliferation6US 8,642,278 B2University of South Florida · 2014